Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence.
D000698:Analgesia; D000818:Animals; D001127:Arginine Vasopressin / Q000031:analogs & derivatives / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D006801:Humans; D009021:Morphine Dependence; D009270:Naloxone / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology*; D010121:Oxytocin / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D014667:Vasopressins / Q000031:analogs & derivatives*
D009842:Oligopeptides; D014667:Vasopressins; D001127:Arginine Vasopressin; D009270:Naloxone; D010121:Oxytocin